Metternich F U, Brusis T
Klinik für HNO-Heilkunde, Kopf- und Halschirurgie, Kliniken der Stadt Köln, Krankenhaus Holweide.
Laryngorhinootologie. 1997 Feb;76(2):88-95. doi: 10.1055/s-2007-997393.
Parastomal neoplasm after total laryngectomy for laryngeal carcinoma represents an extremely serious complication and one of the most formidable therapeutic problems encountered by the head and neck surgeon. Studies about the etiology of parastomal neoplasm have been controversial. The factors most strongly implicated in parastomal neoplasm have been recurrence spawned by metastases to deep cervical lymph nodes, undetected neoplasm at the margin of the laryngectomy resection, neoplastic cell implantation by pre-operative tracheotomy, and the development of an additional primary.
To clarify the controversial aspects of parastomal neoplasm etiology, a systematic analysis of parastomal neoplasm after laryngectomy was performed using data from 10 patients who developed parastomal neoplasm.
Parastomal neoplasm occurred in 7.9%. The tumor site of the primary laryngeal carcinoma was found in 9/10 cases in the subglottic, supraglottic, or transglottic area. These tumor sites correlate with areas of a lymphatic vessel concentration and an increase of intralaryngeal lymphatic drainage. In average the parastomal neoplasms appear 10.3 months after the laryngectomy. Therapy was unsuccessful in spite of extensive surgical interventions.
If the laryngeal carcinoma was resected with margins of healthy tissue, lymphatic metastasis to the pretracheal and paratracheal cervical lymph nodes is the probable cause of parastomal neoplasm. This could be the consequence of the continuous lymphatic drainage between the supraglottic and subglottic area with a midline crossing and an lymphatic outlet to the pretracheal and paratracheal cervical lymph nodes. The cervical metastasis formation cannot be detected due to the limitations in the assessment of small lymph nodes and the inability to ascertain with confidence the presence or absence of metastasis in any one lymph node in ultrasonography, computed tomography, and magnetic resonance imaging and due to the limitations in the removal of lymph nodes in the pretracheal and paratracheal area by means of a functional or radical neck dissection. The method of treatment should be in cases of a subglottic or a supraglottic laryngeal carcinoma an ipsilateral and contralateral pretracheal and paratracheal lymph node removal in combination with the laryngectomy.
喉癌全喉切除术后造口旁肿瘤是一种极其严重的并发症,也是头颈外科医生面临的最棘手的治疗问题之一。关于造口旁肿瘤病因的研究一直存在争议。与造口旁肿瘤关系最密切的因素包括颈部深层淋巴结转移导致的复发、喉切除切除边缘未被发现的肿瘤、术前气管切开导致的肿瘤细胞种植以及额外原发性肿瘤的发生。
为了阐明造口旁肿瘤病因的争议点,我们对10例发生造口旁肿瘤的患者的数据进行了系统分析,以研究喉切除术后造口旁肿瘤。
造口旁肿瘤的发生率为7.9%。在10例患者中,9例原发性喉癌的肿瘤部位位于声门下、声门上或跨声门区域。这些肿瘤部位与淋巴管集中区域以及喉内淋巴引流增加相关。造口旁肿瘤平均在喉切除术后10.3个月出现。尽管进行了广泛的手术干预,治疗仍未成功。
如果喉癌切除时保留了健康组织边缘,气管前和气管旁颈部淋巴结的淋巴转移可能是造口旁肿瘤的原因。这可能是由于声门上和声门下区域之间通过中线交叉的持续淋巴引流以及向气管前和气管旁颈部淋巴结的淋巴引流所致。由于在超声、计算机断层扫描和磁共振成像中评估小淋巴结存在局限性,且无法确定任何一个淋巴结是否存在转移,以及由于功能性或根治性颈清扫术在气管前和气管旁区域切除淋巴结存在局限性,因此无法检测到颈部转移的形成。对于声门下或声门上喉癌病例,治疗方法应是在进行喉切除的同时,切除同侧和对侧的气管前和气管旁淋巴结。